FDA Inspection
Gehring-Montgomery, Inc.Gehring-Montgomery, Inc. – FDA Inspection, Aug 26, 2026
Record Details
This FDA Inspection record concerns Gehring-Montgomery, Inc., with an inspection on August 26, 2026, issued by the Philadelphia District Office, covering human drugs.
View Company Profile
ID · 9f3f4e12-38c7-4849-a877-711d3966536f
Inspection Facts
- Inspection number
- 1335088
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 211.25(a)GMP Training Frequency
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Gehring-Montgomery, Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| February 9, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 3, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Gehring-Montgomery, Inc.
- FDA Inspection 1231890 - 2024-02-09
- FDA Inspection 992250 - 2016-11-03
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.